Table 1.

Occurrence of complications of glucocorticoid therapy in patients with Graves’ orbitopathy (based on Marcocci et al., 2001 [9])

	Oral (n = 27)	Intravenous (n = 41)
Mild to moderate:
Hyperglycemia, gain in body weight, depression, and Cushingoid features	17	27
Severe:
Cardiovascular, cerebrovascular, > 4-fold increase in liver enzymes, acute liver failure, autoimmune hepatitis	10	14

n number of physicians reporting adverse events